Medical Doctor Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Daniel Kim

Gastroenterology Mission Viejo, CA Medical Doctor

NPI 1548648868 CMS profile 4219390

27799 Medical Center Rd Ste 310, Mission Viejo, CA 92691

Open in the dashboard

General payments

$8,632

387 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Daniel Kim of Mission Viejo, CA is reported in the CMS Open Payments database as having received $8,632 across 387 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 78th percentile of Gastroenterology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,991 121
2024 General $2,659 119
2023 General $2,482 129
2022 General $380 17
2021 General $120 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Daniel Kim
  • Gastroenterology median
  • Middle half of Gastroenterology
  • National median

In program year 2025, general payments to Daniel Kim were reported at $2,991. Among 13,050 Gastroenterology profiles paid that year, the median was $639 and the middle half received between $167 and $1,700.

Show as a table
Year Daniel Kim Gastroenterology median Middle half National median
2019 $0 $417 $126–$1,100 $163
2020 $0 $224 $74–$624 $114
2021 $120 $352 $106–$1,054 $132
2022 $380 $448 $129–$1,270 $149
2023 $2,482 $533 $150–$1,390 $160
2024 $2,659 $605 $160–$1,606 $164
2025 $2,991 $639 $167–$1,700 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. AbbVie, Inc. $2,776 130 payments
  2. Janssen Biotech, Inc. $870 32 payments
  3. Takeda Pharmaceuticals U.S.A., Inc. $760 54 payments
  4. Genzyme Corporation $440 20 payments
  5. Salix Pharmaceuticals, a division of Bausch Health US, LLC $382 17 payments
  6. Aimmune Therapeutics, Inc. $358 14 payments
  7. Ardelyx, Inc. $350 13 payments
  8. Madrigal Pharmaceuticals $304 7 payments
  9. Celgene Corporation $281 24 payments
  10. Regeneron Healthcare Solutions, Inc. $179 7 payments
  11. Other $1,933 69 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $8,632 387 payments
Products named General payments · program years 2021–2025
  1. RINVOQ $2,064 104 payments
  2. SKYRIZI Immunology $1,485 73 payments
  3. SKYRIZI Immunology $793 38 payments
  4. ENTYVIO $638 49 payments
  5. TREMFYA $481 15 payments
  6. DUPIXENT $440 20 payments
  7. STELARA $390 17 payments
  8. ZEPOSIA $377 23 payments
  9. IBSRELA $350 13 payments
  10. XIFAXAN $312 14 payments
  11. Other $3,324 132 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 15 drugs

Part D claims

683

Median for Gastroenterology: 569

Drug cost

$58,433

Median for Gastroenterology: $104,976

Branded share of claims

38.7%

Median for Gastroenterology: 31.8%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Linzess Linaclotide Brand 22 $18,254
Trulance Plecanatide Brand 15 $13,617
Plenvu Peg3350/Sod Sul/Nacl/Kcl/Asb/C Brand 43 $5,714
Clenpiq Sod Picosulf/Mag Ox/Citric Ac Brand 27 $4,712
Sutab Sod Sulf/Pot Chloride/Mag Sulf Brand 28 $4,526
Omeprazole Generic 222 $3,142
Sucralfate Generic 21 $1,588
Dicyclomine Hcl Generic 52 $1,401
Colestipol Hcl Generic 27 $1,316
Peg 3350-Electrolyte Sodium Chloride/Nahco3/Kcl/Peg Brand 69 $1,269

The 10 drugs with the highest cost, of 15 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 14,294 Part D prescribers listed as Gastroenterology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 36 billing codes

Paid by Medicare

$89,203

Medicare's payments for the services billed

Medicare patients

359

Average age 75

Services billed

842

207 women, 152 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 68%
Arthritis 55%
Ischemic heart disease 26%
Diabetes 25%
Chronic kidney disease 24%
Osteoporosis 24%
Cancer 20%
Depression 19%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 19 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
SKYRIZI
  • AbbVie, Inc. $603
$603 — —
RINVOQ
  • AbbVie, Inc. $443
$443 — —
ZENPEP
  • AIMMUNE THERAPEUTICS, INC. $235
$235 — —
STELARA
  • Janssen Biotech, Inc. $179
$179 — —
ENTYVIO
  • Takeda Pharmaceuticals U.S.A., Inc. $163
$163 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 19 in the dashboard with a free account

Records

387 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Gastroenterology in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record